Biopharmaceuticals
Venture Capital
News Release - February 2, 2016
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Source: Spero Therapeutics
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.